University of California San Francisco Department of Ophthalmology
University of California San Francisco Department of Ophthalmology
San Francisco, California, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06524882 | |
| Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06380517 | |
| Bevacizumab Treatment For Type 1 ROP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, eye disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Phase 2 | 2026-02-11 | NCT04634578 | |
| A Randomized Trial to Evaluate Sequential vs Simultaneous Patching | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT04378790 |